PMID: 6975849Dec 1, 1981Paper

Characterization of mononuclear blood cell-derived differentiation inducing factors for the human promyelocytic leukemia cell line HL-60

Journal of the National Cancer Institute
I OlssonN Mauritzon

Abstract

A search was made for physiologically produced differentiation inducing factor(s) (DIF) for the human promyelocytic leukemia cell line HL-60. Mononuclear blood cells, when stimulated with various mitogens, produced DIF, which induced differentiation of HL-60 into phagocytizing nitro blue tetrazolium reducing cells with the morphologic characteristic of granulopoietic or myelomonocytic cells. Induction of differentiation occurred equally well in serum-containing and serum-free media. Protein synthesis was necessary for elaboration of DIF, which seems to be of a protein nature inasmuch as it is destroyed by proteases. Gel chromatography showed that one or two species of DIF with apparent molecular weights of 40,000 and 25,000 were produced, depending on the type of mitogen used. At least the 40,000-molecular weight DIF was distinct from the colony stimulating activity (CSA), which was produced simultaneously. Our results suggested a role of lymphocytes and/or monocytes for modulation of myelomonocytic hematopoiesis not mediated by CSA. The physiologic importance remains, however, to be demonstrated.

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.